ENBIO Statistics

Total Valuation

ENBIO has a market cap or net worth of KRW 25.00 billion. The enterprise value is 37.71 billion.

Market Cap	25.00B
Enterprise Value	37.71B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

ENBIO has 10.87 million shares outstanding. The number of shares has increased by 0.65% in one year.

Current Share Class	10.87M
Shares Outstanding	10.87M
Shares Change (YoY)	+0.65%
Shares Change (QoQ)	-0.04%
Owned by Insiders (%)	30.47%
Owned by Institutions (%)	n/a
Float	7.56M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.79
PB Ratio	0.58
P/TBV Ratio	0.58
P/FCF Ratio	n/a
P/OCF Ratio	5.72
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 62.98, with an EV/FCF ratio of -1,721.03.

EV / Earnings	-107.18
EV / Sales	1.20
EV / EBITDA	62.98
EV / EBIT	n/a
EV / FCF	-1,721.03

Financial Position

The company has a current ratio of 2.07, with a Debt / Equity ratio of 0.37.

Current Ratio	2.07
Quick Ratio	0.18
Debt / Equity	0.37
Debt / EBITDA	26.69
Debt / FCF	-729.32
Interest Coverage	-0.86

Financial Efficiency

Return on equity (ROE) is -0.82% and return on invested capital (ROIC) is -0.59%.

Return on Equity (ROE)	-0.82%
Return on Assets (ROA)	-0.52%
Return on Invested Capital (ROIC)	-0.59%
Return on Capital Employed (ROCE)	-1.16%
Revenue Per Employee	393.21M
Profits Per Employee	-4.40M
Employee Count	80
Asset Turnover	0.46
Inventory Turnover	1.51

Taxes

In the past 12 months, ENBIO has paid 26.81 million in taxes.

Income Tax	26.81M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +6.05% in the last 52 weeks. The beta is 0.89, so ENBIO's price volatility has been lower than the market average.

Beta (5Y)	0.89
52-Week Price Change	+6.05%
50-Day Moving Average	2,206.00
200-Day Moving Average	2,358.00
Relative Strength Index (RSI)	67.48
Average Volume (20 Days)	9,893

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ENBIO had revenue of KRW 31.46 billion and -351.79 million in losses. Loss per share was -32.34.

Revenue	31.46B
Gross Profit	9.26B
Operating Income	-559.16M
Pretax Income	-324.98M
Net Income	-351.79M
EBITDA	598.74M
EBIT	-559.16M
Loss Per Share	-32.34

Full Income Statement

Balance Sheet

The company has 3.27 billion in cash and 15.98 billion in debt, giving a net cash position of -12.71 billion or -1,169.57 per share.

Cash & Cash Equivalents	3.27B
Total Debt	15.98B
Net Cash	-12.71B
Net Cash Per Share	-1,169.57
Equity (Book Value)	42.86B
Book Value Per Share	3,945.40
Working Capital	19.63B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.37 billion and capital expenditures -4.40 billion, giving a free cash flow of -21.91 million.

Operating Cash Flow	4.37B
Capital Expenditures	-4.40B
Free Cash Flow	-21.91M
FCF Per Share	-2.02

Full Cash Flow Statement

Margins

Gross margin is 29.44%, with operating and profit margins of -1.78% and -1.12%.

Gross Margin	29.44%
Operating Margin	-1.78%
Pretax Margin	-1.03%
Profit Margin	-1.12%
EBITDA Margin	1.90%
EBIT Margin	-1.78%
FCF Margin	n/a

Dividends & Yields

ENBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.65%
Shareholder Yield	-0.65%
Earnings Yield	-1.41%
FCF Yield	-0.09%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ENBIO has an Altman Z-Score of 1.23 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.23
Piotroski F-Score	4